FDA approves new drug for rare form of ALS
About 2% of ALS patients have a mutation that this drug targets.
About 2% of ALS patients have a mutation that this drug targets.
U.S. Food and Drug Administration
FDA approves Pfizer’s new nasal spray treatment for migraines
Nearly 40 million Americans suffer from migraines, health experts say.
Nearly 40 million Americans suffer from migraines, health experts say.
